Skip to main content
SpringerLink
Log in

Moxifloxacin prophylaxis is associated with higher bacteraemia and adverse event rates than levofloxacin prophylaxis

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. von Baum H, Sigge A, Bommer M, Kern WV, Marre R, Döhner H, Kern P, Reuter S.Moxifloxacin prophylaxis in neutropenic patients. Journal of Antimicrobial Chemotherapy 58: 891-894, No. 4, Oct 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moxifloxacin prophylaxis is associated with higher bacteraemia and adverse event rates than levofloxacin prophylaxis. React. Wkly. 1130, 5 (2006). https://doi.org/10.2165/00128415-200611300-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611300-00011

Keywords

Search

Navigation